Shortcuts

open access

Vol 1, No 2 (2002): Polish Palliative Medicine
Artykuły poglądowe
Published online: 2002-06-04
Get Citation

Disturbances of serum glucose level regulation in patients with advanced neoplastic disease

Maciej Bączyk, Katarzyna Ziemnicka, Ewa Bączyk, Jacek Łuczak
Advances in Palliative Medicine 2002;1(2):49-56.

open access

Vol 1, No 2 (2002): Polish Palliative Medicine
Artykuły poglądowe
Published online: 2002-06-04

Abstract

Disturbances of carbohydrate metabolism and frequent variations of serum glucose level in patients with advanced neoplastic disease are the critical clinical problem. Patients, admitted to the long term medical care units, who have glucose metabolism abnormalities can be divided into two groups: first — are the patients with symptomatic diabetes mellitus, and second — are the patients with periodic carbohydrate metabolism abnormalities without clinical manifestation of diabetes mellitus. These glucose metabolism abnormalities in patients with malignancy can be determined by such factors as: chronic excess of cortisol and katecholamines, and relative predominance of glucagons over insulin, that causes acceleration of lypolysis and glycogenolysis. Mechanism mentioned above lead independently also to marked increase in liver guconeogenesis in association with insulin resistance and disturbances in insuline secretion. Other factors, that may affect serum glucose level regulation, are the cytokines released in excess like TNF-a, IL-1 and interferon. Knowledge about diagnosis and treatment principles of glucose metabolism derangements based on understanding of mechanism that can lead to these disorders, should contribute to better care of this group of patients, thereby improve quality of their life.

Abstract

Disturbances of carbohydrate metabolism and frequent variations of serum glucose level in patients with advanced neoplastic disease are the critical clinical problem. Patients, admitted to the long term medical care units, who have glucose metabolism abnormalities can be divided into two groups: first — are the patients with symptomatic diabetes mellitus, and second — are the patients with periodic carbohydrate metabolism abnormalities without clinical manifestation of diabetes mellitus. These glucose metabolism abnormalities in patients with malignancy can be determined by such factors as: chronic excess of cortisol and katecholamines, and relative predominance of glucagons over insulin, that causes acceleration of lypolysis and glycogenolysis. Mechanism mentioned above lead independently also to marked increase in liver guconeogenesis in association with insulin resistance and disturbances in insuline secretion. Other factors, that may affect serum glucose level regulation, are the cytokines released in excess like TNF-a, IL-1 and interferon. Knowledge about diagnosis and treatment principles of glucose metabolism derangements based on understanding of mechanism that can lead to these disorders, should contribute to better care of this group of patients, thereby improve quality of their life.
Get Citation

Keywords

malignancy; insulin resistance; hyperglycaemia; anorexia

About this article
Title

Disturbances of serum glucose level regulation in patients with advanced neoplastic disease

Journal

Advances in Palliative Medicine

Issue

Vol 1, No 2 (2002): Polish Palliative Medicine

Pages

49-56

Published online

2002-06-04

Bibliographic record

Advances in Palliative Medicine 2002;1(2):49-56.

Keywords

malignancy
insulin resistance
hyperglycaemia
anorexia

Authors

Maciej Bączyk
Katarzyna Ziemnicka
Ewa Bączyk
Jacek Łuczak

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl